Eastman Chemical (EMN) Financials

$82.41 +1.87 (+2.32%)

Closing price 05/27/2025 03:59 PM Eastern

Extended Trading

$82.46 +0.05 (+0.07%)

As of 05/27/2025 06:08 PM Eastern

Annual Income Statements for Eastman Chemical

This table shows Eastman Chemical's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	905	894	793	857	478	759	1,080	1,384	854	848
Consolidated Net Income / (Loss)	908	896	796	867	489	762	1,084	1,388	859	854
Net Income / (Loss) Continuing Operations	908	896	796	867	489	762	1,084	1,388	859	854
Total Pre-Tax Income	1,078	1,087	977	1,082	530	902	1,310	1,289	1,049	1,129
Total Operating Income	1,278	1,302	1,159	1,281	868	1,120	1,478	1,399	1,382	1,384
Total Gross Profit	2,290	2,061	2,137	2,500	1,975	2,234	2,479	2,363	2,357	2,580
Total Revenue	9,382	9,210	10,580	10,476	8,473	9,273	10,151	9,549	9,008	9,648
Operating Revenue	9,382	9,210	10,580	10,476	8,473	9,273	10,151	9,549	9,008	9,648
Total Cost of Revenue	7,092	7,149	8,443	7,976	6,498	7,039	7,672	7,186	6,651	7,068
Operating Cost of Revenue	7,092	7,149	8,443	7,976	6,498	7,039	7,672	7,186	6,651	7,068
Total Operating Expenses	1,012	1,082	935	1,096	1,107	1,111	1,001	964	975	1,196
Selling, General & Admin Expense	736	727	726	795	654	691	721	729	707	771
Research & Development Expense	250	239	264	254	226	234	235	227	223	242
Other Operating Expenses / (Income)	47	38	-6.00	-	-	63	-	-	-	-
Restructuring Charge	-21	78	-49	47	227	126	45	8.00	45	183
Total Other Income / (Expense), net	-200	108	-225	-322	-338	-218	-168	-110	-333	-255
Interest Expense	200	215	182	199	211	218	242	241	340	263
Other Income / (Expense), net	0.00	323	-43	-123	-127	0.00	74	131	7.00	8.00
Income Tax Expense	170	191	181	215	41	140	226	-99	190	275
Net Income / (Loss) Attributable to Noncontrolling Interest	3.00	2.00	3.00	10	11	3.00	4.00	4.00	5.00	6.00
Basic Earnings per Share	$7.75	$7.54	$6.42	$6.35	$3.53	$5.52	$7.65	$9.56	$5.80	$5.71
Weighted Average Basic Shares Outstanding	115.17M	234.69M	237.59M	257.94M	271.72M	135.99M	15.43B	144.80M	147.30M	148.60M
Diluted Earnings per Share	$7.67	$7.49	$6.35	$6.25	$3.50	$5.48	$7.56	$9.47	$5.75	$5.66
Weighted Average Diluted Shares Outstanding	115.17M	234.69M	237.59M	257.94M	271.72M	135.99M	15.43B	144.80M	147.30M	148.60M
Weighted Average Basic & Diluted Shares Outstanding	115.17M	234.69M	237.59M	257.94M	271.72M	135.99M	15.43B	144.80M	147.30M	148.60M
Cash Dividends to Common per Share	$3.26	$3.18	$3.07	$2.83	$2.67	$2.52	$2.30	$2.09	$1.89	$1.66

This table shows Eastman Chemical's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	182	330	180	230	165	310	178	272	134	1.00	301
Consolidated Net Income / (Loss)	183	331	181	231	165	311	179	272	134	2.00	301
Net Income / (Loss) Continuing Operations	183	331	181	231	165	311	179	272	134	2.00	301
Total Pre-Tax Income	253	297	280	287	214	425	199	269	194	28	281
Total Operating Income	302	349	329	337	263	477	256	323	246	122	324
Total Gross Profit	567	554	605	599	532	464	484	584	529	376	541
Total Revenue	2,290	2,245	2,464	2,363	2,310	2,207	2,267	2,324	2,412	2,373	2,709
Operating Revenue	2,290	2,245	2,464	2,363	2,310	2,207	2,267	2,324	2,412	2,373	2,709
Total Cost of Revenue	1,723	1,691	1,859	1,764	1,778	1,743	1,783	1,740	1,883	1,997	2,168
Operating Cost of Revenue	1,723	1,691	1,859	1,764	1,778	1,743	1,783	1,740	1,883	1,997	2,168
Total Operating Expenses	265	205	276	262	269	310	228	261	283	211	217
Selling, General & Admin Expense	182	182	183	180	191	191	160	185	191	172	173
Research & Development Expense	67	66	65	60	59	57	60	60	62	64	68
Other Operating Expenses / (Income)	8.00	5.00	3.00	26	13	-2.00	10	19	11	-	1.00
Restructuring Charge	8.00	-48	25	-4.00	6.00	64	-2.00	-3.00	19	-4.00	-25
Total Other Income / (Expense), net	-49	-52	-49	-50	-49	271	-57	-54	-52	-137	-43
Interest Expense	49	52	49	50	49	52	57	54	52	48	43
Income Tax Expense	70	-34	99	56	49	114	20	-3.00	60	26	-20
Net Income / (Loss) Attributable to Noncontrolling Interest	1.00	1.00	1.00	1.00	0.00	1.00	1.00	0.00	0.00	1.00	0.00
Basic Earnings per Share	$1.58	$2.84	$1.55	$1.96	$1.40	$2.63	$1.50	$2.28	$1.13	$0.07	$2.48
Weighted Average Basic Shares Outstanding	115.46M	115.17M	115.91M	116.86M	117.65M	234.69M	118.56M	118.56M	238.30M	237.59M	239.98M
Diluted Earnings per Share	$1.57	$2.81	$1.53	$1.94	$1.39	$2.61	$1.49	$2.27	$1.12	$0.06	$2.46
Weighted Average Diluted Shares Outstanding	115.46M	115.17M	115.91M	116.86M	117.65M	234.69M	118.56M	118.56M	238.30M	237.59M	239.98M
Weighted Average Basic & Diluted Shares Outstanding	115.46M	115.17M	115.91M	116.86M	117.65M	234.69M	118.56M	118.56M	238.30M	237.59M	239.98M
Cash Dividends to Common per Share	$0.83	-	$0.81	$0.81	$0.81	-	$0.79	$0.79	$0.79	-	$0.76

This table details how cash moves in and out of Eastman Chemical's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	289	55	34	-105	360	-22	35	10	-112	79
Net Cash From Operating Activities	1,287	1,374	975	1,619	1,455	1,504	1,543	1,657	1,385	1,624
Net Cash From Continuing Operating Activities	1,287	1,374	975	1,619	1,455	1,504	1,543	1,657	1,385	1,624
Net Income / (Loss) Continuing Operations	908	896	796	867	489	762	1,084	1,388	859	854
Consolidated Net Income / (Loss)	908	896	796	867	489	762	1,084	1,388	859	854
Depreciation Expense	509	498	477	538	574	611	604	587	580	571
Non-Cash Adjustments To Reconcile Net Income	-1.00	-209	-175	279	338	134	-21	-67	-138	76
Changes in Operating Assets and Liabilities, net	-129	189	-123	-65	54	-3.00	-124	-251	84	123
Net Cash From Investing Activities	-534	-432	392	-29	-394	-480	-463	-643	-655	-693
Net Cash From Continuing Investing Activities	-534	-432	392	-29	-394	-480	-463	-643	-655	-693
Purchase of Property, Plant & Equipment	-599	-828	-611	-578	-396	-431	-528	-649	-626	-652
Acquisitions	0.00	-77	-1.00	-114	-1.00	-48	-3.00	-4.00	-26	-45
Sale of Property, Plant & Equipment	38	456	998	667	0.00	0.00	5.00	14	41	4.00
Other Investing Activities, net	27	17	6.00	-4.00	3.00	-1.00	63	-4.00	-44	0.00
Net Cash From Financing Activities	-454	-888	-1,321	-1,690	-704	-1,043	-1,040	-1,006	-838	-844
Net Cash From Continuing Financing Activities	-454	-888	-1,321	-1,690	-704	-1,043	-1,040	-1,006	-838	-844
Repayment of Debt	-1,012	-1,158	-764	-315	-535	-765	-1,926	-1,044	-2,111	-755
Repurchase of Common Equity	-300	-150	-1,002	-1,000	-60	-325	-400	-350	-145	-103
Payment of Dividends	-379	-376	-381	-375	-358	-343	-318	-296	-280	-244
Issuance of Debt	1,237	796	826	0.00	249	390	1,604	684	1,698	250
Effect of Exchange Rate Changes	-10	1.00	-12	-5.00	3.00	-3.00	-5.00	2.00	-4.00	-8.00

This table details how cash moves in and out of Eastman Chemical's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-419	215	108	15	-49	109	29	-189	106	32	5.00
Net Cash From Operating Activities	-167	540	396	367	-16	452	514	410	-2.00	457	256
Net Cash From Continuing Operating Activities	-167	540	396	367	-16	452	514	410	-2.00	457	256
Net Income / (Loss) Continuing Operations	183	331	181	231	165	311	179	272	134	2.00	301
Consolidated Net Income / (Loss)	183	331	181	231	165	311	179	272	134	2.00	301
Depreciation Expense	126	129	127	126	127	118	120	119	141	117	117
Non-Cash Adjustments To Reconcile Net Income	-123	-11	59	48	-97	-243	14	55	-35	52	-16
Changes in Operating Assets and Liabilities, net	-353	91	29	-38	-211	266	201	-36	-242	286	-146
Net Cash From Investing Activities	-131	-132	-102	-121	-179	248	-182	-246	-252	-206	-158
Net Cash From Continuing Investing Activities	-131	-132	-102	-121	-179	248	-182	-246	-252	-206	-158
Purchase of Property, Plant & Equipment	-147	-175	-121	-117	-186	-175	-236	-241	-176	-193	-164
Acquisitions	0.00	-	-	-	0.00	-3.00	2.00	-3.00	-73	-	-
Divestitures	0.00	-	-	-	0.00	-	22	-	16	-	-
Other Investing Activities, net	16	5.00	19	-4.00	7.00	8.00	30	-2.00	-19	-13	6.00
Net Cash From Financing Activities	-124	-181	-194	-227	148	-593	-299	-353	357	-223	-88
Net Cash From Continuing Financing Activities	-124	-181	-194	-227	148	-593	-299	-353	357	-223	-88
Repayment of Debt	-559	13	-494	-32	-499	-326	-1.00	-486	-345	-358	156
Repurchase of Common Equity	0.00	-100	-100	-	-	-100	-	-	-	-100	-150
Payment of Dividends	-96	-94	-95	-95	-95	-94	-94	-94	-94	-91	-94
Issuance of Debt	531	-	495	-	742	-73	-204	277	796	326	-
Effect of Exchange Rate Changes	3.00	-12	8.00	-	-	2.00	-4.00	-	3.00	4.00	-

This table presents Eastman Chemical's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	15,213	14,633	14,667	15,519	16,083	16,008	15,995	10,325	15,457	15,580
Total Current Assets	4,101	3,481	3,778	4,646	3,541	3,321	3,365	191	2,866	2,878
Cash & Equivalents	837	548	493	459	564	204	226	191	181	293
Accounts Receivable	1,172	1,154	1,277	1,580	1,515	1,375	1,483	-	1,211	1,038
Inventories, net	1,988	1,683	1,894	1,504	1,379	1,662	1,583	-	1,404	1,479
Other Current Assets	104	96	114	1,103	83	80	73	-	70	68
Plant, Property, & Equipment, net	5,615	5,548	5,160	4,996	5,549	5,571	5,600	5,607	5,276	5,130
Plant, Property & Equipment, gross	13,985	13,574	12,942	12,680	13,531	13,081	12,731	-	11,699	11,234
Accumulated Depreciation	8,370	8,026	7,782	7,684	7,982	7,510	7,131	-	6,423	6,104
Total Noncurrent Assets	5,497	5,604	5,729	5,877	6,993	7,116	7,030	4,527	7,315	7,572
Goodwill	3,632	3,646	3,664	3,641	4,465	4,431	4,467	4,527	4,461	4,518
Intangible Assets	1,032	1,138	1,210	1,362	1,792	2,011	2,185	-	2,479	2,650
Other Noncurrent Operating Assets	833	820	855	874	736	674	378	-	375	404
Total Liabilities & Shareholders' Equity	15,213	14,633	14,667	15,519	16,083	16,008	15,995	6,593	15,457	15,580
Total Liabilities	9,361	9,103	9,431	9,731	9,975	9,976	10,117	0.00	10,849	11,559
Total Current Liabilities	2,708	2,576	3,251	2,971	2,038	1,789	1,851	0.00	1,795	2,056
Short-Term Debt	450	541	1,126	747	349	171	243	-	283	431
Accounts Payable	2,258	2,035	2,125	2,133	1,689	1,618	1,608	-	1,512	1,625
Other Current Nonoperating Liabilities	0.00	0.00	0.00	91	0.00	-	-	-	-	-
Total Noncurrent Liabilities	6,653	6,527	6,180	6,760	7,937	8,187	8,266	0.00	9,054	9,503
Long-Term Debt	4,567	4,305	4,025	4,412	5,269	5,611	5,925	-	6,311	6,577
Noncurrent Deferred & Payable Income Tax Liabilities	533	601	671	810	848	915	884	-	1,206	928
Noncurrent Employee Benefit Liabilities	630	667	628	811	1,143	1,016	925	-	1,018	1,297
Other Noncurrent Operating Liabilities	923	954	856	727	677	645	532	-	519	701
Total Equity & Noncontrolling Interests	5,852	5,530	5,236	5,788	6,108	6,032	5,878	6,593	4,608	4,021
Total Preferred & Common Equity	5,779	5,458	5,153	5,704	6,023	5,958	5,803	6,593	4,532	3,941
Total Common Equity	5,779	5,458	5,153	5,704	6,023	5,958	5,803	6,593	4,532	3,941
Common Stock	2,465	2,370	2,317	2,189	2,176	2,107	2,050	-	1,917	1,865
Retained Earnings	10,013	9,490	8,973	8,557	8,080	7,965	7,573	6,802	5,721	5,146
Treasury Stock	-6,385	-6,083	-5,932	-4,860	-3,960	-3,900	-3,575	-	-2,825	-2,680
Accumulated Other Comprehensive Income / (Loss)	-314	-319	-205	-182	-273	-214	-245	-209	-281	-390
Noncontrolling Interest	73	72	83	84	85	74	75	-	76	80

This table presents Eastman Chemical's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	14,971	15,213	15,060	14,945	14,748	14,633	14,594	14,771	14,983	14,667	14,985
Total Current Assets	3,901	4,101	3,937	3,842	3,638	3,481	3,567	3,671	3,973	3,778	4,105
Cash & Equivalents	418	837	622	514	499	548	439	410	599	493	461
Accounts Receivable	1,259	1,172	1,332	1,329	1,274	1,154	1,149	1,205	1,337	1,277	1,594
Inventories, net	2,116	1,988	1,904	1,900	1,769	1,683	1,721	1,960	1,944	1,894	1,975
Other Current Assets	108	104	79	99	96	96	258	96	93	114	75
Plant, Property, & Equipment, net	5,639	5,615	5,589	5,529	5,535	5,548	5,426	5,402	5,258	5,160	4,982
Plant, Property & Equipment, gross	14,130	13,985	13,916	13,717	13,651	13,574	13,382	13,361	13,153	12,942	12,645
Accumulated Depreciation	8,491	8,370	8,327	8,188	8,116	8,026	7,956	7,959	7,895	7,782	7,663
Total Noncurrent Assets	5,431	5,497	5,534	5,574	5,575	5,604	5,601	5,698	5,752	5,729	5,898
Goodwill	3,642	3,632	3,655	3,641	3,644	3,646	3,643	3,697	3,703	3,664	3,644
Intangible Assets	1,021	1,032	1,072	1,086	1,110	1,138	1,148	1,180	1,203	1,210	1,206
Other Noncurrent Operating Assets	768	833	807	847	821	820	810	821	846	855	1,048
Total Liabilities & Shareholders' Equity	14,971	15,213	15,060	14,945	14,748	14,633	14,594	14,771	14,983	14,667	14,985
Total Liabilities	9,027	9,361	9,332	9,246	9,140	9,103	9,170	9,419	9,721	9,431	9,518
Total Current Liabilities	2,269	2,708	2,590	2,741	2,618	2,576	2,615	2,787	2,971	3,251	3,207
Short-Term Debt	285	450	448	697	740	541	640	844	1,014	1,126	1,086
Accounts Payable	1,984	2,258	2,142	2,044	1,878	2,035	1,940	1,943	1,957	2,125	2,121
Total Noncurrent Liabilities	6,758	6,653	6,742	6,505	6,522	6,527	6,555	6,632	6,750	6,180	6,311
Long-Term Debt	4,736	4,567	4,606	4,336	4,340	4,305	4,580	4,593	4,636	4,025	3,979
Noncurrent Deferred & Payable Income Tax Liabilities	512	533	517	576	588	601	549	573	662	671	756
Noncurrent Employee Benefit Liabilities	624	630	652	655	663	667	611	622	629	628	746
Other Noncurrent Operating Liabilities	886	923	967	938	931	954	815	844	823	856	830
Total Equity & Noncontrolling Interests	5,944	5,852	5,728	5,699	5,608	5,530	5,424	5,352	5,262	5,236	5,467
Total Preferred & Common Equity	5,871	5,779	5,654	5,627	5,538	5,458	5,352	5,281	5,188	5,153	5,384
Total Common Equity	5,871	5,779	5,654	5,627	5,538	5,458	5,352	5,281	5,188	5,153	5,384
Common Stock	2,478	2,465	2,437	2,419	2,390	2,370	2,354	2,344	2,327	2,317	2,303
Retained Earnings	10,099	10,013	9,780	9,694	9,559	9,490	9,274	9,190	9,013	8,973	9,065
Treasury Stock	-6,385	-6,385	-6,285	-6,184	-6,083	-6,083	-5,982	-5,982	-5,932	-5,932	-5,832
Accumulated Other Comprehensive Income / (Loss)	-321	-314	-278	-302	-328	-319	-294	-271	-220	-205	-152
Noncontrolling Interest	73	73	74	72	70	72	72	71	74	83	83

This table displays calculated financial ratios and metrics derived from Eastman Chemical's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.87%	-12.95%	0.99%	23.64%	-8.63%	-8.65%	6.30%	6.01%	-6.63%	1.27%
EBITDA Growth	-15.83%	33.27%	-6.07%	28.97%	-24.03%	-19.71%	1.84%	7.52%	0.31%	20.65%
EBIT Growth	-21.35%	45.61%	-3.63%	56.28%	-33.84%	-27.84%	1.44%	10.15%	-0.22%	18.27%
NOPAT Growth	0.30%	13.65%	-8.01%	28.17%	-15.36%	-22.64%	-18.81%	33.12%	8.10%	18.14%
Net Income Growth	1.34%	12.56%	-8.19%	77.30%	-35.83%	-29.70%	-21.90%	61.58%	0.59%	12.81%
EPS Growth	2.40%	17.95%	1.60%	78.57%	-36.13%	-27.51%	-20.17%	64.70%	1.59%	13.88%
Operating Cash Flow Growth	-6.33%	40.92%	-39.78%	11.27%	-3.26%	-2.53%	-6.88%	19.64%	-14.72%	13.33%
Free Cash Flow Firm Growth	-23.42%	-30.08%	1.23%	28.87%	8.02%	349.72%	-119.34%	182.68%	-31.49%	157.57%
Invested Capital Growth	2.08%	-0.67%	-6.48%	-5.22%	-3.86%	-1.78%	16.64%	-8.05%	2.65%	-1.73%
Revenue Q/Q Growth	0.41%	-1.77%	-2.94%	5.10%	-0.22%	-1.81%	0.14%	1.86%	-0.41%	-1.27%
EBITDA Q/Q Growth	7.65%	47.02%	-25.46%	14.52%	0.15%	-4.26%	-4.60%	-0.24%	3.85%	9.85%
EBIT Q/Q Growth	9.98%	71.59%	-32.57%	25.87%	0.82%	-6.12%	-6.62%	-0.52%	5.39%	12.62%
NOPAT Q/Q Growth	25.81%	33.21%	-28.17%	23.78%	16.19%	-1.04%	-23.74%	25.07%	5.61%	11.34%
Net Income Q/Q Growth	2.25%	52.64%	-32.20%	66.41%	1.45%	-1.04%	-29.61%	36.75%	-0.81%	14.48%
EPS Q/Q Growth	2.68%	51.62%	-29.83%	68.01%	0.57%	-1.26%	-28.95%	37.25%	-0.69%	14.11%
Operating Cash Flow Q/Q Growth	7.34%	-0.36%	2.85%	1.50%	-15.41%	-4.39%	6.49%	18.27%	-11.73%	5.87%
Free Cash Flow Firm Q/Q Growth	-6.75%	78.94%	-29.73%	43.03%	-11.88%	-10.03%	-159.84%	357.22%	-21.72%	174.60%
Invested Capital Q/Q Growth	-1.26%	-4.02%	-1.76%	-4.48%	-1.84%	-4.04%	-4.89%	-12.62%	0.95%	-1.75%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.41%	22.38%	20.20%	23.86%	23.31%	24.09%	24.42%	24.75%	26.17%	26.74%
EBITDA Margin	19.05%	23.05%	15.06%	16.19%	15.52%	18.67%	21.24%	22.17%	21.86%	20.35%
Operating Margin	13.62%	14.14%	10.95%	12.23%	10.24%	12.08%	14.56%	14.65%	15.34%	14.34%
EBIT Margin	13.62%	17.64%	10.55%	11.05%	8.75%	12.08%	15.29%	16.02%	15.42%	14.43%
Profit (Net Income) Margin	9.68%	9.73%	7.52%	8.28%	5.77%	8.22%	10.68%	14.54%	9.54%	8.85%
Tax Burden Percent	84.23%	82.43%	81.47%	80.13%	92.26%	84.48%	82.75%	107.68%	81.89%	75.64%
Interest Burden Percent	84.35%	66.89%	87.54%	93.44%	71.53%	80.54%	84.41%	84.25%	75.52%	81.11%
Effective Tax Rate	15.77%	17.57%	18.53%	19.87%	7.74%	15.52%	17.25%	-7.68%	18.11%	24.36%
Return on Invested Capital (ROIC)	10.84%	10.88%	9.22%	9.44%	7.03%	8.08%	11.14%	14.24%	10.40%	9.67%
ROIC Less NNEP Spread (ROIC-NNEP)	6.87%	6.93%	6.09%	6.20%	1.17%	4.88%	8.21%	11.86%	6.25%	6.92%
Return on Net Nonoperating Assets (RNNOA)	5.11%	5.76%	5.22%	5.13%	1.02%	4.72%	6.24%	10.54%	9.51%	12.78%
Return on Equity (ROE)	15.96%	16.65%	14.44%	14.58%	8.06%	12.80%	17.38%	24.78%	19.91%	22.44%
Cash Return on Invested Capital (CROIC)	8.79%	11.55%	15.92%	14.81%	10.97%	9.87%	-4.22%	22.63%	7.78%	11.41%
Operating Return on Assets (OROA)	8.56%	11.09%	7.39%	7.33%	4.62%	7.00%	11.79%	11.87%	8.95%	8.80%
Return on Assets (ROA)	6.08%	6.12%	5.27%	5.49%	3.05%	4.76%	8.24%	10.77%	5.54%	5.40%
Return on Common Equity (ROCE)	15.75%	16.41%	14.22%	14.37%	7.95%	12.64%	17.28%	24.62%	19.55%	21.97%
Return on Equity Simple (ROE_SIMPLE)	15.71%	16.42%	15.45%	15.20%	8.12%	12.79%	18.68%	21.05%	18.95%	21.67%
Net Operating Profit after Tax (NOPAT)	1,076	1,073	944	1,026	801	946	1,223	1,506	1,132	1,047
NOPAT Margin	11.47%	11.65%	8.93%	9.80%	9.45%	10.20%	12.05%	15.78%	12.56%	10.85%
Net Nonoperating Expense Percent (NNEP)	3.97%	3.96%	3.14%	3.24%	5.87%	3.20%	2.93%	2.38%	4.15%	2.75%
Return On Investment Capital (ROIC_SIMPLE)	9.90%	10.34%	9.09%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	75.59%	77.62%	79.80%	76.14%	76.69%	75.91%	75.58%	75.25%	73.83%	73.26%
SG&A Expenses to Revenue	7.84%	7.89%	6.86%	7.59%	7.72%	7.45%	7.10%	7.63%	7.85%	7.99%
R&D to Revenue	2.66%	2.60%	2.50%	2.42%	2.67%	2.52%	2.32%	2.38%	2.48%	2.51%
Operating Expenses to Revenue	10.79%	11.75%	8.84%	10.46%	13.07%	11.98%	9.86%	10.10%	10.82%	12.40%
Earnings before Interest and Taxes (EBIT)	1,278	1,625	1,116	1,158	741	1,120	1,552	1,530	1,389	1,392
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,787	2,123	1,593	1,696	1,315	1,731	2,156	2,117	1,969	1,963
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.83	1.89	1.76	2.63	2.03	1.56	1.48	1.65	1.94	1.97
Price to Tangible Book Value (P/TBV)	9.49	15.28	32.59	21.39	0.00	0.00	0.00	5.26	0.00	0.00
Price to Revenue (P/Rev)	1.13	1.12	0.86	1.43	1.44	1.00	0.84	1.14	0.98	0.81
Price to Earnings (P/E)	11.70	11.52	11.47	17.50	25.59	12.27	7.93	7.85	10.29	9.17
Dividend Yield	3.57%	3.66%	4.05%	2.54%	2.96%	3.68%	3.76%	2.76%	3.16%	3.17%
Earnings Yield	8.55%	8.68%	8.72%	5.72%	3.91%	8.15%	12.61%	12.74%	9.72%	10.91%
Enterprise Value to Invested Capital (EV/IC)	1.48	1.49	1.40	1.87	1.56	1.29	1.23	1.05	1.39	1.36
Enterprise Value to Revenue (EV/Rev)	1.58	1.59	1.31	1.89	2.05	1.61	1.44	1.12	1.70	1.51
Enterprise Value to EBITDA (EV/EBITDA)	8.30	6.91	8.68	11.66	13.21	8.65	6.76	5.04	7.76	7.42
Enterprise Value to EBIT (EV/EBIT)	11.61	9.03	12.40	17.08	23.44	13.36	9.40	6.98	11.00	10.47
Enterprise Value to NOPAT (EV/NOPAT)	13.78	13.67	14.65	19.27	21.69	15.82	11.92	7.09	13.50	13.92
Enterprise Value to Operating Cash Flow (EV/OCF)	11.53	10.68	14.19	12.22	11.94	9.95	9.45	6.44	11.03	8.97
Enterprise Value to Free Cash Flow (EV/FCFF)	17.01	12.88	8.49	12.29	13.91	12.95	0.00	4.46	18.04	11.79
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.86	0.88	0.98	0.89	0.92	0.96	1.05	0.00	1.43	1.74
Long-Term Debt to Equity	0.78	0.78	0.77	0.76	0.86	0.93	1.01	0.00	1.37	1.64
Financial Leverage	0.74	0.83	0.86	0.83	0.88	0.97	0.76	0.89	1.52	1.85
Leverage Ratio	2.62	2.72	2.74	2.66	2.64	2.69	2.11	2.30	3.60	4.16
Compound Leverage Factor	2.21	1.82	2.40	2.48	1.89	2.16	1.78	1.94	2.72	3.37
Debt to Total Capital	46.16%	46.70%	49.59%	47.13%	47.91%	48.94%	51.20%	0.00%	58.86%	63.54%
Short-Term Debt to Total Capital	4.14%	5.21%	10.84%	6.82%	2.98%	1.45%	2.02%	0.00%	2.53%	3.91%
Long-Term Debt to Total Capital	42.02%	41.49%	38.75%	40.30%	44.93%	47.49%	49.19%	0.00%	56.34%	59.63%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.67%	0.69%	0.80%	0.77%	0.72%	0.63%	0.62%	0.00%	0.68%	0.73%
Common Equity to Total Capital	53.17%	52.60%	49.61%	52.11%	51.36%	50.43%	48.17%	100.00%	40.46%	35.73%
Debt to EBITDA	2.81	2.28	3.23	3.04	4.27	3.34	2.86	0.00	3.35	3.57
Net Debt to EBITDA	2.34	2.02	2.92	2.77	3.84	3.22	2.76	0.00	3.26	3.42
Long-Term Debt to EBITDA	2.56	2.03	2.53	2.60	4.01	3.24	2.75	0.00	3.21	3.35
Debt to NOPAT	4.66	4.52	5.45	5.03	7.02	6.11	5.04	0.00	5.83	6.69
Net Debt to NOPAT	3.88	4.00	4.93	4.58	6.31	5.90	4.86	0.00	5.67	6.41
Long-Term Debt to NOPAT	4.24	4.01	4.26	4.30	6.58	5.93	4.84	0.00	5.58	6.28
Altman Z-Score	2.60	2.66	2.45	2.75	2.23	2.18	2.24	0.00	1.97	1.84
Noncontrolling Interest Sharing Ratio	1.27%	1.44%	1.51%	1.42%	1.31%	1.25%	0.60%	0.68%	1.81%	2.10%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.51	1.35	1.16	1.56	1.74	1.86	1.82	0.00	1.60	1.40
Quick Ratio	0.74	0.66	0.54	0.69	1.02	0.88	0.92	0.00	0.78	0.65
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	872	1,139	1,629	1,609	1,249	1,156	-463	2,393	847	1,236
Operating Cash Flow to CapEx	229.41%	369.35%	0.00%	0.00%	367.42%	348.96%	295.03%	260.94%	236.75%	250.62%
Free Cash Flow to Firm to Interest Expense	4.36	5.30	8.95	8.09	5.92	5.30	-1.91	9.93	2.49	4.70
Operating Cash Flow to Interest Expense	6.44	6.39	5.36	8.14	6.90	6.90	6.38	6.88	4.07	6.17
Operating Cash Flow Less CapEx to Interest Expense	3.63	4.66	7.48	8.58	5.02	4.92	4.21	4.24	2.35	3.71
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.63	0.63	0.70	0.66	0.53	0.58	0.77	0.74	0.58	0.61
Accounts Receivable Turnover	8.07	7.58	7.41	6.77	5.86	6.49	0.00	0.00	8.01	8.62
Inventory Turnover	3.86	4.00	4.97	5.53	4.27	4.34	0.00	0.00	4.61	4.73
Fixed Asset Turnover	1.68	1.72	2.08	1.99	1.52	1.66	1.81	1.75	1.73	1.89
Accounts Payable Turnover	3.30	3.44	3.97	4.17	3.93	4.36	0.00	0.00	4.24	4.22
Days Sales Outstanding (DSO)	45.25	48.17	49.28	53.92	62.25	56.25	0.00	0.00	45.56	42.33
Days Inventory Outstanding (DIO)	94.47	91.31	73.45	65.97	85.41	84.13	0.00	0.00	79.11	77.15
Days Payable Outstanding (DPO)	110.47	106.20	92.04	87.45	92.88	83.64	0.00	0.00	86.08	86.40
Cash Conversion Cycle (CCC)	29.24	33.29	30.69	32.43	54.78	56.74	0.00	0.00	38.59	33.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	10,032	9,828	9,894	10,579	11,162	11,610	11,820	10,134	11,021	10,736
Invested Capital Turnover	0.94	0.93	1.03	0.96	0.74	0.79	0.92	0.90	0.83	0.89
Increase / (Decrease) in Invested Capital	204	-66	-685	-583	-448	-210	1,686	-887	285	-189
Enterprise Value (EV)	14,838	14,671	13,833	19,779	17,369	14,968	14,583	10,677	15,275	14,571
Market Capitalization	10,585	10,301	9,092	14,995	12,230	9,316	8,566	10,868	8,786	7,776
Book Value per Share	$49.86	$46.03	$42.95	$42.43	$44.46	$43.82	$41.44	$45.87	$30.88	$26.52
Tangible Book Value per Share	$9.62	$5.68	$2.33	$5.21	($1.73)	($3.56)	($6.06)	$14.37	($16.41)	($21.71)
Total Capital	10,869	10,376	10,387	10,947	11,726	11,814	12,046	6,593	11,202	11,029
Total Debt	5,017	4,846	5,151	5,159	5,618	5,782	6,168	0.00	6,594	7,008
Total Long-Term Debt	4,567	4,305	4,025	4,412	5,269	5,611	5,925	0.00	6,311	6,577
Net Debt	4,180	4,298	4,658	4,700	5,054	5,578	5,942	-191	6,413	6,715
Capital Expenditures (CapEx)	561	372	-387	-89	396	431	523	635	585	648
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,006	898	1,160	1,963	1,288	1,499	1,531	0.00	1,173	960
Debt-free Net Working Capital (DFNWC)	1,843	1,446	1,653	2,422	1,852	1,703	1,757	191	1,354	1,253
Net Working Capital (NWC)	1,393	905	527	1,675	1,503	1,532	1,514	191	1,071	822
Net Nonoperating Expense (NNE)	168	177	148	159	312	184	139	118	273	193
Net Nonoperating Obligations (NNO)	4,180	4,298	4,658	4,791	5,054	5,578	5,942	3,541	6,413	6,715
Total Depreciation and Amortization (D&A)	509	498	477	538	574	611	604	587	580	571
Debt-free, Cash-free Net Working Capital to Revenue	10.72%	9.75%	10.96%	18.74%	15.20%	16.17%	15.08%	0.00%	13.02%	9.95%
Debt-free Net Working Capital to Revenue	19.64%	15.70%	15.62%	23.12%	21.86%	18.37%	17.31%	2.00%	15.03%	12.99%
Net Working Capital to Revenue	14.85%	9.83%	4.98%	15.99%	17.74%	16.52%	14.91%	2.00%	11.89%	8.52%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$7.75	$7.54	$6.42	$6.35	$3.53	$5.52	$7.65	$9.56	$5.80	$5.71
Adjusted Weighted Average Basic Shares Outstanding	115.17M	234.69M	237.59M	257.94M	271.72M	135.99M	139.78M	142.97M	146.49M	147.81M
Adjusted Diluted Earnings per Share	$7.67	$7.49	$6.35	$6.25	$3.50	$5.48	$7.56	$9.47	$5.75	$5.66
Adjusted Weighted Average Diluted Shares Outstanding	115.17M	234.69M	237.59M	257.94M	271.72M	135.99M	139.78M	142.97M	146.49M	147.81M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	115.17M	234.69M	237.59M	257.94M	271.72M	135.99M	139.78M	142.97M	146.49M	147.81M
Normalized Net Operating Profit after Tax (NOPAT)	1,059	1,138	904	1,064	1,010	1,053	1,260	985	1,169	1,185
Normalized NOPAT Margin	11.29%	12.35%	8.55%	10.16%	11.92%	11.35%	12.42%	10.31%	12.97%	12.29%
Pre Tax Income Margin	11.49%	11.80%	9.23%	10.33%	6.26%	9.73%	12.91%	13.50%	11.65%	11.70%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.39	7.56	6.13	5.82	3.51	5.14	6.41	6.35	4.09	5.29
NOPAT to Interest Expense	5.38	4.99	5.19	5.16	3.80	4.34	5.05	6.25	3.33	3.98
EBIT Less CapEx to Interest Expense	3.59	5.83	8.26	6.27	1.64	3.16	4.25	3.71	2.36	2.83
NOPAT Less CapEx to Interest Expense	2.58	3.26	7.31	5.61	1.92	2.36	2.89	3.62	1.61	1.52
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	41.74%	41.96%	47.86%	43.25%	73.21%	45.01%	29.34%	21.33%	32.60%	28.57%
Augmented Payout Ratio	74.78%	58.71%	173.74%	158.59%	85.48%	87.66%	66.24%	46.54%	49.48%	40.63%

This table displays calculated financial ratios and metrics derived from Eastman Chemical's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.87%	1.72%	8.69%	1.68%	-4.23%	-7.00%	-16.32%	-16.52%	-11.13%	-11.92%	-0.40%
EBITDA Growth	9.74%	-19.66%	21.28%	4.75%	0.78%	148.95%	-14.74%	-19.34%	-14.76%	-67.70%	-11.27%
EBIT Growth	14.83%	-26.83%	28.52%	4.33%	6.91%	290.98%	-20.99%	-24.18%	-26.13%	-80.26%	-12.43%
NOPAT Growth	7.72%	11.43%	-7.64%	-16.95%	19.34%	3,905.51%	-33.65%	13.66%	-28.00%	-98.04%	-14.94%
Net Income Growth	10.91%	6.43%	1.12%	-15.07%	23.13%	15,450.00%	-40.53%	5.84%	-43.22%	-99.47%	-14.97%
EPS Growth	12.95%	7.66%	2.68%	-14.54%	24.11%	4,250.00%	-39.43%	11.82%	-37.78%	-97.83%	-4.28%
Operating Cash Flow Growth	-943.75%	19.47%	-22.96%	-10.49%	-700.00%	-1.09%	100.78%	67.35%	-111.76%	6.28%	-53.20%
Free Cash Flow Firm Growth	-142.71%	-55.44%	377.67%	491.53%	-59.60%	-40.17%	-95.46%	-107.83%	37.81%	-32.45%	91.90%
Invested Capital Growth	3.51%	2.08%	-0.78%	-1.55%	-1.20%	-0.67%	1.68%	4.40%	-5.83%	-6.48%	-9.07%
Revenue Q/Q Growth	2.00%	-8.89%	4.27%	2.29%	4.67%	-2.65%	-2.45%	-3.65%	1.64%	-12.40%	-2.69%
EBITDA Q/Q Growth	-10.46%	4.82%	-1.51%	18.72%	11.11%	58.24%	-14.93%	14.21%	61.92%	-45.81%	-19.53%
EBIT Q/Q Growth	-13.47%	6.08%	-2.37%	28.14%	12.88%	86.33%	-20.74%	31.30%	101.64%	-62.35%	-23.94%
NOPAT Q/Q Growth	-43.84%	82.89%	-21.59%	33.76%	18.93%	51.58%	-29.49%	92.21%	1,849.87%	-97.49%	20.78%
Net Income Q/Q Growth	-44.71%	82.87%	-21.65%	40.00%	-46.95%	73.74%	-34.19%	102.99%	6,600.00%	-99.34%	17.12%
EPS Q/Q Growth	-44.13%	83.66%	-21.13%	39.57%	-46.74%	75.17%	-34.36%	102.68%	1,766.67%	-97.56%	21.18%
Operating Cash Flow Q/Q Growth	-130.93%	36.36%	7.90%	2,393.75%	-103.54%	-12.06%	25.37%	20,600.00%	-100.44%	78.52%	4.49%
Free Cash Flow Firm Q/Q Growth	-175.46%	-36.81%	-32.29%	32.27%	38.17%	577.40%	155.50%	-113.65%	16.61%	-48.65%	-4.14%
Invested Capital Q/Q Growth	5.13%	-1.26%	-0.57%	0.28%	3.67%	-4.02%	-1.34%	0.64%	4.23%	-1.76%	1.30%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.76%	24.68%	24.55%	25.35%	23.03%	21.02%	21.35%	25.13%	21.93%	15.84%	19.97%
EBITDA Margin	18.69%	21.29%	18.51%	19.59%	16.88%	26.96%	16.59%	19.02%	16.04%	10.07%	16.28%
Operating Margin	13.19%	15.55%	13.35%	14.26%	11.39%	21.61%	11.29%	13.90%	10.20%	5.14%	11.96%
EBIT Margin	13.19%	15.55%	13.35%	14.26%	11.39%	21.61%	11.29%	13.90%	10.20%	5.14%	11.96%
Profit (Net Income) Margin	7.99%	14.74%	7.35%	9.78%	7.14%	14.09%	7.90%	11.70%	5.56%	0.08%	11.11%
Tax Burden Percent	72.33%	111.45%	64.64%	80.49%	77.10%	73.18%	89.95%	101.12%	69.07%	7.14%	107.12%
Interest Burden Percent	83.77%	85.10%	85.11%	85.16%	81.37%	89.10%	77.73%	83.28%	78.86%	22.95%	86.73%
Effective Tax Rate	27.67%	-11.45%	35.36%	19.51%	22.90%	26.82%	10.05%	-1.12%	30.93%	92.86%	-7.12%
Return on Invested Capital (ROIC)	8.61%	16.37%	7.91%	10.20%	7.80%	14.77%	9.38%	13.58%	6.81%	0.38%	13.21%
ROIC Less NNEP Spread (ROIC-NNEP)	7.84%	15.00%	7.22%	9.35%	7.02%	13.92%	8.29%	12.44%	6.09%	0.24%	12.24%
Return on Net Nonoperating Assets (RNNOA)	6.23%	11.17%	5.99%	8.08%	6.22%	11.58%	7.17%	11.05%	5.44%	0.20%	9.93%
Return on Equity (ROE)	14.85%	27.54%	13.90%	18.27%	14.02%	26.35%	16.55%	24.63%	12.25%	0.58%	23.14%
Cash Return on Invested Capital (CROIC)	7.08%	8.79%	9.17%	9.89%	9.99%	11.55%	6.27%	4.87%	14.26%	15.92%	21.93%
Operating Return on Assets (OROA)	8.31%	9.77%	8.41%	8.78%	6.98%	13.59%	7.16%	9.21%	6.81%	3.60%	8.35%
Return on Assets (ROA)	5.03%	9.27%	4.63%	6.02%	4.38%	8.86%	5.01%	7.75%	3.71%	0.06%	7.75%
Return on Common Equity (ROCE)	14.66%	27.19%	13.71%	18.04%	13.83%	25.97%	16.31%	24.28%	12.07%	0.57%	22.80%
Return on Equity Simple (ROE_SIMPLE)	15.77%	0.00%	15.71%	15.75%	16.74%	0.00%	10.97%	13.43%	13.38%	0.00%	21.81%
Net Operating Profit after Tax (NOPAT)	218	389	213	271	203	349	230	327	170	8.71	347
NOPAT Margin	9.54%	17.33%	8.63%	11.48%	8.78%	15.82%	10.16%	14.05%	7.04%	0.37%	12.81%
Net Nonoperating Expense Percent (NNEP)	0.77%	1.37%	0.69%	0.84%	0.78%	0.85%	1.09%	1.14%	0.72%	0.14%	0.97%
Return On Investment Capital (ROIC_SIMPLE)	1.99%	3.58%	-	-	-	3.36%	-	-	-	0.08%	-
Cost of Revenue to Revenue	75.24%	75.32%	75.45%	74.65%	76.97%	78.98%	78.65%	74.87%	78.07%	84.16%	80.03%
SG&A Expenses to Revenue	7.95%	8.11%	7.43%	7.62%	8.27%	8.65%	7.06%	7.96%	7.92%	7.25%	6.39%
R&D to Revenue	2.93%	2.94%	2.64%	2.54%	2.55%	2.58%	2.65%	2.58%	2.57%	2.70%	2.51%
Operating Expenses to Revenue	11.57%	9.13%	11.20%	11.09%	11.65%	14.05%	10.06%	11.23%	11.73%	8.89%	8.01%
Earnings before Interest and Taxes (EBIT)	302	349	329	337	263	477	256	323	246	122	324
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	428	478	456	463	390	595	376	442	387	239	441
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.73	1.83	2.31	2.05	2.15	1.89	1.64	1.82	1.86	1.76	1.53
Price to Tangible Book Value (P/TBV)	8.40	9.49	14.11	12.81	15.16	15.28	15.67	23.81	34.22	32.59	15.44
Price to Revenue (P/Rev)	1.08	1.13	1.40	1.26	1.30	1.12	0.94	0.98	0.94	0.86	0.76
Price to Earnings (P/E)	11.01	11.70	14.78	13.05	12.85	11.52	15.03	13.59	13.94	11.47	7.05
Dividend Yield	3.72%	3.57%	2.89%	3.29%	3.19%	3.66%	4.26%	3.88%	3.82%	4.05%	4.53%
Earnings Yield	9.09%	8.55%	6.76%	7.66%	7.78%	8.68%	6.65%	7.36%	7.17%	8.72%	14.19%
Enterprise Value to Invested Capital (EV/IC)	1.41	1.48	1.73	1.58	1.62	1.49	1.33	1.42	1.43	1.40	1.28
Enterprise Value to Revenue (EV/Rev)	1.58	1.58	1.88	1.76	1.82	1.59	1.46	1.50	1.44	1.31	1.19
Enterprise Value to EBITDA (EV/EBITDA)	8.12	8.30	10.60	10.20	10.61	6.91	9.45	9.75	9.15	8.68	6.05
Enterprise Value to EBIT (EV/EBIT)	11.26	11.61	15.14	14.80	15.38	9.03	14.41	14.50	13.21	12.40	7.81
Enterprise Value to NOPAT (EV/NOPAT)	13.58	13.78	20.56	18.79	18.37	13.67	16.94	15.79	16.83	14.65	9.84
Enterprise Value to Operating Cash Flow (EV/OCF)	13.05	11.53	14.67	12.24	12.16	10.68	9.90	13.13	15.45	14.19	13.64
Enterprise Value to Free Cash Flow (EV/FCFF)	20.20	17.01	18.80	15.82	16.14	12.88	21.43	29.73	9.74	8.49	5.58
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.84	0.86	0.88	0.88	0.91	0.88	0.96	1.02	1.07	0.98	0.93
Long-Term Debt to Equity	0.80	0.78	0.80	0.76	0.77	0.78	0.84	0.86	0.88	0.77	0.73
Financial Leverage	0.80	0.74	0.83	0.86	0.89	0.83	0.86	0.89	0.89	0.86	0.81
Leverage Ratio	2.57	2.62	2.66	2.69	2.74	2.72	2.72	2.76	2.74	2.74	2.68
Compound Leverage Factor	2.16	2.23	2.26	2.29	2.23	2.42	2.11	2.29	2.16	0.63	2.32
Debt to Total Capital	45.79%	46.16%	46.87%	46.90%	47.53%	46.70%	49.04%	50.39%	51.78%	49.59%	48.09%
Short-Term Debt to Total Capital	2.60%	4.14%	4.16%	6.49%	6.92%	5.21%	6.01%	7.82%	9.29%	10.84%	10.31%
Long-Term Debt to Total Capital	43.19%	42.02%	42.72%	40.40%	40.61%	41.49%	43.03%	42.57%	42.49%	38.75%	37.78%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.67%	0.67%	0.69%	0.67%	0.65%	0.69%	0.68%	0.66%	0.68%	0.80%	0.79%
Common Equity to Total Capital	53.54%	53.17%	52.44%	52.43%	51.82%	52.60%	50.28%	48.95%	47.54%	49.61%	51.12%
Debt to EBITDA	2.75	2.81	3.04	3.19	3.26	2.28	3.62	3.60	3.50	3.23	2.37
Net Debt to EBITDA	2.52	2.34	2.67	2.86	2.94	2.02	3.31	3.33	3.13	2.92	2.15
Long-Term Debt to EBITDA	2.60	2.56	2.77	2.74	2.78	2.03	3.17	3.04	2.87	2.53	1.86
Debt to NOPAT	4.60	4.66	5.91	5.87	5.64	4.52	6.48	5.83	6.44	5.45	3.85
Net Debt to NOPAT	4.22	3.88	5.18	5.27	5.09	4.00	5.93	5.39	5.75	4.93	3.50
Long-Term Debt to NOPAT	4.34	4.24	5.38	5.06	4.82	4.01	5.68	4.93	5.28	4.26	3.03
Altman Z-Score	2.44	2.40	2.55	2.43	2.45	2.40	2.24	2.29	2.26	2.23	2.24
Noncontrolling Interest Sharing Ratio	1.24%	1.27%	1.31%	1.29%	1.32%	1.44%	1.42%	1.44%	1.41%	1.51%	1.46%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.72	1.51	1.52	1.40	1.39	1.35	1.36	1.32	1.34	1.16	1.28
Quick Ratio	0.74	0.74	0.75	0.67	0.68	0.66	0.61	0.58	0.65	0.54	0.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-140	185	293	432	327	415	61	-110	809	694	1,351
Operating Cash Flow to CapEx	-113.61%	308.57%	327.27%	313.68%	-8.60%	258.29%	217.80%	170.12%	-1.14%	236.79%	156.10%
Free Cash Flow to Firm to Interest Expense	-2.85	3.56	5.97	8.64	6.67	7.98	1.07	-2.04	15.56	14.45	31.42
Operating Cash Flow to Interest Expense	-3.41	10.38	8.08	7.34	-0.33	8.69	9.02	7.59	-0.04	9.52	5.95
Operating Cash Flow Less CapEx to Interest Expense	-6.41	7.02	5.61	5.00	-4.12	5.33	4.88	3.13	-3.42	5.50	2.14
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.63	0.63	0.63	0.62	0.61	0.63	0.63	0.66	0.67	0.70	0.70
Accounts Receivable Turnover	7.39	8.07	7.53	7.22	6.98	7.58	6.84	6.91	6.89	7.41	6.60
Inventory Turnover	3.62	3.86	3.94	3.66	3.79	4.00	4.01	4.11	4.52	4.97	4.76
Fixed Asset Turnover	1.68	1.68	1.70	1.67	1.69	1.72	1.80	1.90	2.00	2.08	2.15
Accounts Payable Turnover	3.64	3.30	3.50	3.55	3.67	3.44	3.65	3.79	4.07	3.97	4.20
Days Sales Outstanding (DSO)	49.38	45.25	48.46	50.56	52.32	48.17	53.39	52.79	53.00	49.28	55.26
Days Inventory Outstanding (DIO)	100.75	94.47	92.60	99.67	96.20	91.31	91.11	88.72	80.83	73.45	76.67
Days Payable Outstanding (DPO)	100.16	110.47	104.28	102.95	99.36	106.20	100.11	96.36	89.66	92.04	87.01
Cash Conversion Cycle (CCC)	49.97	29.24	36.78	47.28	49.16	33.29	44.39	45.15	44.17	30.69	44.93
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	10,547	10,032	10,160	10,218	10,189	9,828	10,240	10,379	10,313	9,894	10,071
Invested Capital Turnover	0.90	0.94	0.92	0.89	0.89	0.93	0.92	0.97	0.97	1.03	1.03
Increase / (Decrease) in Invested Capital	358	204	-80	-161	-124	-66	169	437	-639	-685	-1,004
Enterprise Value (EV)	14,823	14,838	17,589	16,117	16,533	14,671	13,646	14,719	14,774	13,833	12,932
Market Capitalization	10,147	10,585	13,083	11,526	11,882	10,301	8,793	9,621	9,649	9,092	8,245
Book Value per Share	$50.98	$49.86	$48.38	$47.83	$47.07	$46.03	$45.14	$44.32	$43.67	$42.95	$43.84
Tangible Book Value per Share	$10.49	$9.62	$7.93	$7.65	$6.66	$5.68	$4.73	$3.39	$2.37	$2.33	$4.35
Total Capital	10,965	10,869	10,782	10,732	10,688	10,376	10,644	10,789	10,912	10,387	10,532
Total Debt	5,021	5,017	5,054	5,033	5,080	4,846	5,220	5,437	5,650	5,151	5,065
Total Long-Term Debt	4,736	4,567	4,606	4,336	4,340	4,305	4,580	4,593	4,636	4,025	3,979
Net Debt	4,603	4,180	4,432	4,519	4,581	4,298	4,781	5,027	5,051	4,658	4,604
Capital Expenditures (CapEx)	147	175	121	117	186	175	236	241	176	193	164
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,499	1,006	1,173	1,284	1,261	898	1,153	1,318	1,417	1,160	1,523
Debt-free Net Working Capital (DFNWC)	1,917	1,843	1,795	1,798	1,760	1,446	1,592	1,728	2,016	1,653	1,984
Net Working Capital (NWC)	1,632	1,393	1,347	1,101	1,020	905	952	884	1,002	527	898
Net Nonoperating Expense (NNE)	35	58	32	40	38	38	51	55	36	6.71	46
Net Nonoperating Obligations (NNO)	4,603	4,180	4,432	4,519	4,581	4,298	4,816	5,027	5,051	4,658	4,604
Total Depreciation and Amortization (D&A)	126	129	127	126	127	118	120	119	141	117	117
Debt-free, Cash-free Net Working Capital to Revenue	16.01%	10.72%	12.55%	14.04%	13.85%	9.75%	12.30%	13.42%	13.79%	10.96%	13.97%
Debt-free Net Working Capital to Revenue	20.48%	19.64%	19.21%	19.66%	19.32%	15.70%	16.98%	17.60%	19.61%	15.62%	18.20%
Net Working Capital to Revenue	17.43%	14.85%	14.42%	12.04%	11.20%	9.83%	10.15%	9.00%	9.75%	4.98%	8.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.58	$2.84	$1.55	$1.96	$1.40	$2.63	$1.50	$2.28	$1.13	$0.07	$2.48
Adjusted Weighted Average Basic Shares Outstanding	115.46M	115.17M	115.91M	116.86M	117.65M	234.69M	118.56M	118.56M	238.30M	237.59M	239.98M
Adjusted Diluted Earnings per Share	$1.57	$2.81	$1.53	$1.94	$1.39	$2.61	$1.49	$2.27	$1.12	$0.06	$2.46
Adjusted Weighted Average Diluted Shares Outstanding	115.46M	115.17M	115.91M	116.86M	117.65M	234.69M	118.56M	118.56M	238.30M	237.59M	239.98M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	115.46M	115.17M	115.91M	116.86M	117.65M	234.69M	118.56M	118.56M	238.30M	237.59M	239.98M
Normalized Net Operating Profit after Tax (NOPAT)	224	211	229	268	207	396	228	224	183	83	209
Normalized NOPAT Margin	9.79%	9.39%	9.29%	11.34%	8.98%	17.94%	10.08%	9.64%	7.59%	3.48%	7.73%
Pre Tax Income Margin	11.05%	13.23%	11.36%	12.15%	9.26%	19.26%	8.78%	11.57%	8.04%	1.18%	10.37%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.16	6.71	6.71	6.74	5.37	9.17	4.49	5.98	4.73	2.54	7.53
NOPAT to Interest Expense	4.46	7.48	4.34	5.42	4.14	6.71	4.04	6.05	3.27	0.18	8.07
EBIT Less CapEx to Interest Expense	3.16	3.35	4.24	4.40	1.57	5.81	0.35	1.52	1.35	-1.48	3.72
NOPAT Less CapEx to Interest Expense	1.46	4.11	1.87	3.08	0.34	3.35	-0.10	1.59	-0.12	-3.84	4.26
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	41.04%	41.74%	42.68%	42.66%	40.67%	41.96%	63.54%	52.61%	54.32%	47.86%	32.62%
Augmented Payout Ratio	73.43%	74.78%	76.46%	65.24%	40.67%	58.71%	89.10%	94.92%	54.32%	173.74%	169.93%

Frequently Asked Questions About Eastman Chemical's Financials

When does Eastman Chemical's fiscal year end?

According to the most recent income statement we have on file, Eastman Chemical's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Eastman Chemical's net income changed over the last 9 years?

Eastman Chemical's net income appears to be on a downward trend, with a most recent value of $908 million in 2024, rising from $854 million in 2015. The previous period was $896 million in 2023. Check out Eastman Chemical's forecast to explore projected trends and price targets.

What is Eastman Chemical's operating income?

Eastman Chemical's total operating income in 2024 was $1.28 billion, based on the following breakdown:

Total Gross Profit: $2.29 billion
Total Operating Expenses: $1.01 billion

How has Eastman Chemical revenue changed over the last 9 years?

Over the last 9 years, Eastman Chemical's total revenue changed from $9.65 billion in 2015 to $9.38 billion in 2024, a change of -2.8%.

How much debt does Eastman Chemical have?

Eastman Chemical's total liabilities were at $9.36 billion at the end of 2024, a 2.8% increase from 2023, and a 19.0% decrease since 2015.

How much cash does Eastman Chemical have?

In the past 9 years, Eastman Chemical's cash and equivalents has ranged from $181 million in 2016 to $837 million in 2024, and is currently $837 million as of their latest financial filing in 2024.

How has Eastman Chemical's book value per share changed over the last 9 years?

Over the last 9 years, Eastman Chemical's book value per share changed from 26.52 in 2015 to 49.86 in 2024, a change of 88.0%.

Related Companies

This page (NYSE:EMN) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Eastman Chemical (EMN) Financials

Frequently Asked Questions About Eastman Chemical's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Eastman Chemical (EMN) Financials

Annual Income Statements for Eastman Chemical

Quarterly Income Statements for Eastman Chemical

Annual Cash Flow Statements for Eastman Chemical

Quarterly Cash Flow Statements for Eastman Chemical

Annual Balance Sheets for Eastman Chemical

Quarterly Balance Sheets for Eastman Chemical

Annual Metrics And Ratios for Eastman Chemical

Quarterly Metrics And Ratios for Eastman Chemical

Frequently Asked Questions About Eastman Chemical's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools